Antti Perheentupa

Antti Perheentupa

Auto-generated profile, based on publicly available information

Antti Perheentupa

Department of Obstetrics and Gynecology Reproductive Medicine and Andrology Turku University Hospital University of Turku Turku Finland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
Sherif BayoumySherif Bayoumy
Sherif Bayoumy
HHHeidi Hyytiä
Heidi Hyytiä
JLJanne Leivo
Janne Leivo
STSheikh Talha
Sheikh Talha
KHKaisa Huhtinen
Kaisa Huhtinen
KPKim Pettersson
Kim Pettersson
Cancer antigen 125 (CA125) is a widely used biomarker in monitoring of epithelial ovarian cancer (EOC). Due to insufficient cancer specificity of CA125, its diagnostic use is severely compromised. Abnormal glycosylation of CA125 is a unique feature of ovarian cancer cells and could improve differential diagnosis of the disease. Here we describe the development of a quantitative lateral flow immunoassay (LFIA) of aberrantly glycosylated CA125 which is widely superior to the conventional CA125 immunoassay (CA125IA). With a 30 min read-out time, the LFIA showed 72% sensitivity, at 98% specificity using diagnostically challenging samples with marginally elevated CA125 (35–200 U/mL), in comparison to 16% sensitivity with the CA125IA. We envision the clinical use of the developed LFIA to be based on the substantially enhanced disease specificity against the many benign conditions confounding the diagnostic evaluation and against other cancers.

24 September 2018 in Andrology
Verified
Journal Article
Open access
PDF file
WRW. Rodprasert
W. Rodprasert
HVH. E. Virtanen
H. E. Virtanen
SSS. Sadov
S. Sadov
APA. Perheentupa
A. Perheentupa
NSN. E. Skakkebæk
N. E. Skakkebæk
JTJ. Toppari
J. Toppari
Background: Finnish men used to have higher semen quality than Danish men. However, recent studies showed that semen quality in Finland has declined, but it has been relatively stable in Denmark.Objective: This study aimed to compare new data on semen quality of the young Finnish men to that of Danish men.Materials and methods: In this cross‐sectional study, 18‐ to 19‐year‐old men residing in Turku, Finland and Copenhagen, Denmark, were invited to participate in 2008–2011. Each man filled in a questionnaire, provided one semen sample and underwent andrological examination. Semen samples were analyzed according to WHO. Multiway ANOVA was used to adjust semen variables for duration of sexual abstinence and age (and time from ejaculation to the start of semen analysis for sperm motility).Results: Altogether 287 Finnish men and 873 Danish men participated in the study. The adjusted median sperm concentrations were 49 and 47 million/mL for Finnish and Danish men, respectively (p = 0.48). The adjusted median total sperm counts were 148 million in Finland and 146 million in Denmark (p = 0.87). The adjusted median percentages of morphologically normal spermatozoa were 6.9% in Finland and 6.5% in Denmark, p = 0.27. Finnish men had higher adjusted median percentages of motile spermatozoa (A+B+C) than Danish men (80% vs. 69%, p < 0.001). The proportion of men who had low semen quality (sperm concentration, percentage of morphologically normal spermatozoa or percentage of progressively motile spermatozoa below WHO reference limits) was lower in Finland (25.4%) than in Denmark (34.6%), p = 0.004.Discussion: Considerable percentage of men in both countries had low semen quality. The deteriorating semen quality in Finland may result in decreasing fecundity, which is a cause of concern.Conclusion: The formerly high semen quality in Finland has converged to the lower Danish levels. Our findings demonstrate the importance of continuing surveillance of semen quality.

1 January 2021 in International Journal of Hyperthermia
Verified
Journal Article
Open access
TSTeija Sainio
Teija Sainio
JSJani Saunavaara
Jani Saunavaara
GKGaber Komar
Gaber Komar
SMSami Mattila
Sami Mattila
SOSaara Otonkoski
Saara Otonkoski
RSRoberto Blanco Sequeiros
Roberto Blanco Sequeiros
To investigate the feasibility of using an apparent diffusion coefficient (ADC) classification in predicting the technical outcome of magnetic resonance imaging-guided high-intensity focused ultras...

1 October 2004 in Fertility and Sterility
Verified
Journal Article
Closed access
APAntti Perheentupa
Antti Perheentupa
ARAimo Ruokonen
Aimo Ruokonen
JTJuha S. Tapanainen
Juha S. Tapanainen

1 January 2020 in International Journal of Hyperthermia
Verified
Journal Article
Open access
SOSaara Otonkoski
Saara Otonkoski
TSTeija Sainio
Teija Sainio
GKGaber Komar
Gaber Komar
VSVisa Suomi
Visa Suomi
JSJani Saunavaara
Jani Saunavaara
KJKirsi Joronen
Kirsi Joronen
Uterine fibroids are the most common benign neoplasms in women. The administration of intravenous oxytocin is known to increase the efficacy of a non-invasive thermal ablation method (MR-HIFU) for ...

19 December 2022 in International Journal of Hyperthermia
Verified
Journal Article
Open access
SOSaara Otonkoski
Saara Otonkoski
TSTeija Sainio
Teija Sainio
SMSami Mattila
Sami Mattila
RSRoberto Blanco Sequieros
Roberto Blanco Sequieros
APAntti Perheentupa
Antti Perheentupa
KJKirsi Joronen
Kirsi Joronen
Uterine fibroids are the most common benign tumors in healthy women. High Intensity Focused Ultrasound (HIFU) is a modern, noninvasive thermal ablation method for treating uterine fibroids. There i...